Neomycin is an antibiotic that interferes with bacterial protein synthesis by binding primarily to the 30S subunit of bacterial ribosomes. Many vaccines contain trace amounts of neomycin to ...

You'll need many copies of the vector/gene loop for your genetic vaccine. These copies can be produced with the help of bacteria. Vectors are capable of self-replicating when within a bacterial ...

However, three other approaches are also now used to create vaccines for viral diseases. These are subunit (also used for bacterial vaccines), viral vector and nucleic acid. Recombinant subunit ...

Use the growth medium to grow new copies of the Clostridium tetani bacteria. With a toxoid vaccine, the goal is to condition the immune system to combat not an invading virus or bacteria but ...

In preclinical studies using mice with advanced colorectal cancer and melanoma (skin cancer), the bacterial vaccine was able to boost the immune system enough to suppress tumor growth, and in many ...

Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with 'kill switches' that can be triggered to stop the bacteria after they activate ...

Antibiotic-resistant bacteria are a serious public health threat. Understanding the biology of these bacteria—such as how ...

and repeated antigen patterns prompt an improved immune response compared with that initiated by split or recombinant subunit vaccines. But because they do not contain the core genetic material ...

Antibiotic alternatives are needed for controlling diseases that cause high mortality. A vaccine discovery for Clostridial dermatitis in turkeys could lead to developing improved prophylactic ...

Rifaximin is a semi-synthetic derivative of rifampin and acts by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase blocking one of the steps in transcription. This results in ...